Kelyniam Global Revenues Grow 54% from Prior Year

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Canton, CT, April 7, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc.(OTC: KLYG), a manufacturer of custom cranial implants, announces preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% vs. sales of $1,206,227 in 2012. The Kelyniam product fit and quick turnaround has captured the attention of surgeons throughout the United States. The revenue increase reflects the continued rollout in many additional hospitals. The company will provide financials on their website, kelyniam.com, when they become available in final form from the Accounting Firm.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC